To validate the tumor-suppressive effect of USP7 inhibitors, we repeated the xenograft experiment by comparing tumor growth between the parental and USP7 CRISPR-targeted SW480 cells (Figure S7D). This evidence concerns the gene USP7 and neoplasm.